NEW YORK (GenomeWeb News) – UK-based LabTech International will handle sales and service in the UK, Ireland, and France for Fluxion Biosciences’ BioFlux research tools for live-cell imaging and analysis.
Fluxion’s BioFlux 200 is used for live-cell imaging applications, such as cell adhesion and microbial biofilm studies.
"Labtech has exceptional penetration of cell biology markets and their contacts are an ideal fit for our products,” Mark Atlas, director of sales for San Francisco-based Fluxion, said in a statement.
Further terms of the partnership were not disclosed.